PharVision Advisers’s TSMC TSM Stock Holding History

PharVision Advisers’s Portfolio TSM Stock Details TSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,428	Closed	-$399K	–	1009
2025 Q3	$399K	Buy	+1,428	New	+$349K	0.22%	82

Other funds holding TSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's TSM Position: Q4 2025 in Review

PharVision Advisers sold out of TSMC (TSM) in Q4 2025, closing a stake of 1,428 shares — an estimated $399K sold.

PharVision Advisers first reported a position in TSM in Q3 2025 and held it in 1 quarter. The position peaked at $399K in Q3 2025. 3,116 funds tracked by Wall St. Rank hold TSM as of Q4 2025.

PharVision Advisers reported no remaining TSMC position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,428 TSMC shares in Q4 2025, an estimated $399K.
PharVision Advisers first reported a position in TSMC in Q3 2025 and held it in 1 quarter.
PharVision Advisers's TSMC position peaked at $399K in Q3 2025.
3,116 funds tracked by Wall St. Rank held TSMC as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.